Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review [0.03%]
根据中重度成人特应性皮炎的医生评估疾病严重程度和患者报告的结果定义治疗目标：系统评价
Michela Iannone,Giulia Tonini,Agata Janowska et al.
Michela Iannone et al.
Background: Atopic dermatitis (AD) is a chronically relapsing skin disease. Although a definitive cure is not available, appropriate treatment can control the disease. The advent of biologic drugs has led to the need for ...
Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States [0.03%]
美国宫颈癌、阴道癌、外阴癌、肛门癌和口咽癌患者的医疗资源利用及成本的增量变化趋势分析研究
Vimalanand Prabhu,Niranjan Kathe,Kunal Saxena et al.
Vimalanand Prabhu et al.
Introduction: Human papillomavirus (HPV) cause cancers in a variety of anatomic sites presenting at various stages of disease. Current economic assessments rely on HPV-related cancer cost estimates from data prior to the ...
A single-centre, observational, retrospective, real-life study evaluating adalimumab biosimilar ABP 501 in the treatment of plaque-type psoriasis and psoriatic arthritis in originator-naïve patients and in patients undergoing non-medical switch from originator [0.03%]
评估阿达木单抗类似物ABP 501在阿达木单抗初治患者和非医疗转换的原研药物患者中治疗斑块状银屑病和银屑病关节炎的有效性和安全性：一项单一中心、观察性、回顾性的真实世界研究
A Giunta,A Zangrilli,M Bavetta et al.
A Giunta et al.
Background: ABP 501 is a biosimilar to the anti-tumor necrosis factor-alfa monoclonal antibody adalimumab and despite its effectiveness and safety in the treatment of psoriasis was demonstrated in randomized clinical tria...
Observational Study
Current medical research and opinion. 2021 Jul;37(7):1099-1102. DOI:10.1080/03007995.2021.1923467 2021
Development of a visual, patient-reported tool for assessing the multi-dimensional burden of endometriosis [0.03%]
一种可视化的、以患者报告为基础的评估子宫内膜异位症多维度负担的工具的研发
Sawsan As-Sanie,Marc R Laufer,Stacey A Missmer et al.
Sawsan As-Sanie et al.
Objective: Inadequate communication about endometriosis symptom burden between women and healthcare providers is a barrier for optimal treatment. This study describes the development of the EndoWheel, a patient-reported a...
Treatment patterns following initiation of generic glatiramer acetate among patients with multiple sclerosis from two large real-world databases in the United States [0.03%]
来自美国两大真实世界数据库的多发性硬化症患者的通用型醋酸格拉替雷治疗模式
Jessica K Alexander,Rinat Ariely,Ying Wu et al.
Jessica K Alexander et al.
Introduction: To better understand treatment patterns in US patients with multiple sclerosis (MS) initiating generic glatiramer acetate (GA), this study examined adherence, discontinuation and switching patterns from gene...
Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax [0.03%]
维奈克拉治疗CLL/SLL患者的现实世界用药模式及医疗费用研究
Kerry A Rogers,Bruno Emond,Ameur M Manceur et al.
Kerry A Rogers et al.
Objective: This study aimed to describe treatment sequencing and healthcare costs among chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients treated with venetoclax in a US managed care population....
Differences between the quality aspects of various generic and branded docetaxel formulations [0.03%]
不同厂家多西他赛仿制药物与原研药物的质量差异分析
Chen Yiding,Huang Zhongyi
Chen Yiding
Docetaxel is a widely prescribed chemotherapy drug in oncology and post expiry of its patent, the drug has been marketed as a generic by multiple manufacturers. It is also classified as a narrow therapeutic window drug. Through enhanced per...
Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study [0.03%]
日本血液系统恶性肿瘤患者的抗真菌治疗的医疗资源利用及经济负担：一项基于数据库的回顾性研究
Rie Ueno,Shinichi Nishimura,Go Fujimoto et al.
Rie Ueno et al.
Objective: To examine treatment patterns of real-world antifungal management of patients at high risk of invasive fungal infections (IFI) and evaluate healthcare resource utilization and costs associated with antifungal m...
Observational Study
Current medical research and opinion. 2021 Jul;37(7):1121-1134. DOI:10.1080/03007995.2021.1927691 2021
Use of PD-1 and PD-L1 inhibitors after first-line therapy in esophageal cancer patients in the US [0.03%]
美国食管癌患者一线治疗后的PD-1和PD-L1抑制剂使用情况
Jason C Allaire,Mark Balk,Soraya Azmi et al.
Jason C Allaire et al.
Introduction: Esophageal cancer (EC) makes up 3.2% of all cancers but ranks sixth among cancer-related deaths worldwide. This real-world analysis determined the use of PD-1/PD-L1 (PD[L]1) inhibitors in EC patients after r...
Costs of minor bleeds in atrial fibrillation patients using a non-vitamin K antagonist oral anticoagulant [0.03%]
非维生素K抗凝口服药物治疗房颤患者的小出血成本分析研究
Darko Mitrovic,Marlies Plomp,Richard Folkeringa et al.
Darko Mitrovic et al.
Background: A very common side effect of non-vitamin K antagonist oral anticoagulant (NOAC) is (minor) bleeding. Data about impact and costs of minor bleeds in NOAC therapy is still limited or not present in current liter...
Observational Study
Current medical research and opinion. 2021 Sep;37(9):1461-1466. DOI:10.1080/03007995.2021.1929893 2021